The Pharma Letter
PrivateLast Round
Series A
Extension
May 14, 2026
Total Funding Raised
$135M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
The Pharma Letter is a media company that provides high-value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries.
Sector
Healthcare & Life Sciences
Verticals
News & Media, Digital Publishing, Biotechnology, Podcasts
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Pharma Letter Comparables
Compare The Pharma Letter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cox Enterprises | 78% | |
| EVERSANA | 78% | |
| Boston Globe Media | 77% |
The Pharma Letter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 14, 2026 | ||||
| Series A Extension | May 14, 2026 | ||||
| Series A | Jun 9, 2022 |
The Pharma Letter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series A |
| Co-Win Ventures | Series A, Seed |
| YuanBio Venture Capital | Series A, Seed |
| Baidu Ventures | Series A |
| GF Xinde Investment Management | Series A Extension |
| Lapam Capital | Series A Extension |
| CAS Star | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$40M round led by Lapam Capital.
- May 14, 2026
$40M round led by Lapam Capital.
The Pharma Letter Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about The Pharma Letter's valuation, stock price, and market status.
Is The Pharma Letter a public or private company?
The Pharma Letter is a private company.
What is the current stock price of The Pharma Letter?
The Pharma Letter is a private company with no public stock price. No recent secondary market data is available.
How much is The Pharma Letter worth (valuation)?
Valuation information for The Pharma Letter is not publicly available.
Can I buy The Pharma Letter stock?
The Pharma Letter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was The Pharma Letter's last funding round?
The Pharma Letter's most recent funding round was Series A Extension on May 14, 2026.
Who are the main investors in The Pharma Letter?
Key investors in The Pharma Letter include Lapam Capital, Medfine Capital.
Will The Pharma Letter IPO soon?
No public IPO plans have been announced for The Pharma Letter.
How can I track The Pharma Letter secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor The Pharma Letter's secondary market activity and sign up for updates.